Phase I/II studies of the toxicity and immunogenicity of recombinant gp160 and p24 vaccines in HIV-infected individuals.

Abstract

Sorry, we couldn't extract an abstract for this paper.

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.